MG
SRTA

Michael Gelband’s Strata Critical Medical Inc SRTA Stock Holding History

Michael Gelband’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,817
Closed -$205K – 1551
2025
Q2 		$205K Buy
+50,817
New +$165K ﹤0.01% 1310
2023
Q4 		– Sell
-12,502
Closed -$32K – 1500
2023
Q3 		$32K Buy
+12,502
New +$43.9K ﹤0.01% 1621
2022
Q2 		– Sell
-161,881
Closed -$1.37M – 1963
2022
Q1 		$1.37M Buy
+161,881
New +$1.14M 0.02% 961

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's SRTA Position: Q3 2025 in Review

Michael Gelband sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 50,817 shares — an estimated $205K sold.

Michael Gelband first reported a position in SRTA in Q1 2022 and held it in 3 quarters. The position peaked at $1.37M in Q1 2022. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • Michael Gelband reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • Michael Gelband sold 50,817 Strata Critical Medical Inc shares in Q3 2025, an estimated $205K.
  • Michael Gelband first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 3 quarters.
  • Michael Gelband's Strata Critical Medical Inc position peaked at $1.37M in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.